Financials
- Market Capitalization 1.82 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-25.35
市销率
26.85
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2064 | VIR Vir Biotechnology, Inc. - Common Stock | 10.84 USD | -4.16% | +10.84% | +22.62% | +81.27% | 1.83 B USD | ||
| 2070 | INBX Inhibrx Biosciences, Inc. - Common Stock | 123.64 USD | -0.23% | +19.31% | +54.69% | +53.44% | 1.82 B USD | ||
| 2076 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.87 USD | -1.83% | +0.23% | +19.50% | -6.20% | 1.80 B USD | ||
| 2084 | FTRE Fortrea Holdings Inc. - Common Stock | 18.81 USD | -0.27% | +3.69% | -3.98% | +92.73% | 1.79 B USD |